China Resources Boya Bio-pharmaceutical Group Co (SZSE:300294) EPS (Basic) : ¥0.79 (TTM As of Dec. 2024)

View and export this data going back to 2012. Start your Free Trial

What is China Resources Boya Bio-pharmaceutical Group Co EPS (Basic)?

China Resources Boya Bio-pharmaceutical Group Co's basic earnings per share (Basic EPS) for the three months ended in Dec. 2024 was ¥-0.03. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Dec. 2024 was ¥0.79.

China Resources Boya Bio-pharmaceutical Group Co's EPS (Diluted) for the three months ended in Dec. 2024 was ¥-0.03. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was ¥0.79.

China Resources Boya Bio-pharmaceutical Group Co's EPS without NRI for the three months ended in Dec. 2024 was ¥0.10. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2024 was 0.82.

During the past 12 months, China Resources Boya Bio-pharmaceutical Group Co's average EPS without NRIGrowth Rate was 114.30% per year. During the past 3 years, the average EPS without NRI Growth Rate was -4.10% per year. During the past 5 years, the average EPS without NRI Growth Rate was -11.80% per year. During the past 10 years, the average EPS without NRI Growth Rate was 1.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, China Resources Boya Bio-pharmaceutical Group Co's highest 3-Year average EPS without NRI Growth Rate was 65.00% per year. The lowest was -21.60% per year. And the median was 9.90% per year.

China Resources Boya Bio-pharmaceutical Group Co EPS (Basic) Historical Data

The historical data trend for China Resources Boya Bio-pharmaceutical Group Co's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Resources Boya Bio-pharmaceutical Group Co EPS (Basic) Chart

China Resources Boya Bio-pharmaceutical Group Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

EPS (Basic)

Get a 7-Day Free Trial

0.61

0.79

0.86

0.47

0.79

China Resources Boya Bio-pharmaceutical Group Co Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
EPS (Basic)	Get a 7-Day Free Trial															-0.45	0.30	0.33	0.19	-0.03

China Resources Boya Bio-pharmaceutical Group Co EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

China Resources Boya Bio-pharmaceutical Group Co's Basic EPS for the fiscal year that ended in Dec. 2024 is calculated as

Basic EPS (A: Dec. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(396.992	-	0)	/	502.521
	=	0.79

China Resources Boya Bio-pharmaceutical Group Co's Basic EPS for the quarter that ended in Dec. 2024 is calculated as

Basic EPS (Q: Dec. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-15.712	-	0)	/	500.193
	=	-0.03

EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.79

China Resources Boya Bio-pharmaceutical Group Co (SZSE:300294) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

China Resources Boya Bio-pharmaceutical Group Co EPS (Basic) Related Terms

Thank you for viewing the detailed overview of China Resources Boya Bio-pharmaceutical Group Co's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

China Resources Boya Bio-pharmaceutical Group Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » China Resources Boya Bio-pharmaceutical Group Co Ltd (SZSE:300294) » Definitions » EPS (Basic)

Comparable Companies

Traded in Other Exchanges

N/A

Address

Number 333, Huiquan Road, High-tech Industrial Park, Jiangxi Province, Fuzhou, CHN, 344000

Website

https://www.china-boya.com

China Resources Boya Bio-pharmaceutical Group Co Ltd is a China-based medical industry group that integrates biochemical drugs, chemical drugs, and active pharmaceutical ingredients. It is engaged in the provision of medical and health products and services. The product categories of the company include blood products, biochemical drugs, chemical medicines and others. Some of the company's blood products include human albumin, rabies immunoglobulin, intravenous human immunoglobulin and human fibrinogen.

Executives

Liang Xiao Ming	Directors, executives
Li Shou Sun	Executives
Zhang Shi Fang	Executives
Tu Yan Shi	Directors, executives
Chen Bing	Executives
Liao Xin Xi	Directors, executives
Fan Yi Qin	Secretary, Director
Jiang Guo Liang	Supervisors
Xu Jian Xin	Director
Duan Hong Zhuan	Executives
Chen Hai Yan	Executives
Hong Da Cheng	Director

China Resources Boya Bio-pharmaceutical Group Co Headlines

No Headlines